Literature DB >> 19005757

Mechanisms of excessive esophageal acid exposure in patients with reflux esophagitis.

Katsuhiko Iwakiri1, Noriyuki Kawami, Hirohito Sano, Yuriko Tanaka, Mariko Umezawa, Makoto Kotoyori, Yoshio Hoshihara, Choitsu Sakamoto.   

Abstract

The pathophysiology of excessive esophageal acid exposure, including the way refluxed acid extends towards the proximal esophagus, in patients with reflux esophagitis (RE), is not yet clear. For 3 h after a meal, concurrent esophageal manometry and pH monitoring was carried out on 14 patients with severe RE, 15 patients with mild RE, and 15 healthy subjects. At 2 cm above the proximal margin of the lower esophageal sphincter (LES) there was no difference between the three groups in the total number of acid-reflux episodes, the rate of transient LES relaxations (TLESRs), or the rate of acid reflux during TLESRs. The rate of acid reflux at 7 cm above the proximal margin of the LES, during TLESRs, in patients with severe RE (50.9%, median) was, however, significantly higher than in patients with mild RE (35.7%) and healthy subjects (15.4%). In addition, the rate of acid reflux during TLESRs in patients with mild RE was significantly higher than in healthy subjects. Both the amplitude and the success rate of primary peristalsis in patients with severe RE were significantly lower than those of healthy subjects and patients with mild RE but there was no difference between healthy subjects and patients with mild RE. The cause of excessive acid exposure in patients with RE is the difference in the way refluxed acid extends towards the proximal esophagus and acid bolus clearance, not the number of acid-reflux episodes.

Entities:  

Mesh:

Year:  2008        PMID: 19005757     DOI: 10.1007/s10620-008-0542-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  13 in total

1.  Association between reflux esophagitis and/or hiatus hernia and gastric mucosal atrophy level in Japan.

Authors:  Katsuhiko Iwakiri; Yuriko Tanaka; Yoshinori Hayashi; Makoto Kotoyori; Noriyuki Kawami; Akihiko Kawakami; Choitsu Sakamoto
Journal:  J Gastroenterol Hepatol       Date:  2007-12       Impact factor: 4.029

2.  Effect of peristaltic dysfunction on esophageal volume clearance.

Authors:  P J Kahrilas; W J Dodds; W J Hogan
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

3.  Criteria for objective definition of transient lower esophageal sphincter relaxation.

Authors:  R H Holloway; R Penagini; A C Ireland
Journal:  Am J Physiol       Date:  1995-01

4.  Motor events underlying gastro-oesophageal reflux in ambulant patients with reflux oesophagitis.

Authors:  R Penagini; M N Schoeman; J Dent; M D Tippett; R H Holloway
Journal:  Neurogastroenterol Motil       Date:  1996-06       Impact factor: 3.598

5.  Transient lower esophageal sphincter relaxations (TLESRs) are the major mechanism of gastroesophageal reflux but are not the cause of reflux disease.

Authors:  Katsuhiko Iwakiri; Yoshinori Hayashi; Makoto Kotoyori; Yuriko Tanaka; Akihiko Kawakami; Choitsu Sakamoto; Richard H Holloway
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

6.  Composition of the postprandial refluxate in patients with gastroesophageal reflux disease.

Authors:  D Sifrim; R Holloway; J Silny; J Tack; A Lerut; J Janssens
Journal:  Am J Gastroenterol       Date:  2001-03       Impact factor: 10.864

7.  Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux.

Authors:  J Dent; R H Holloway; J Toouli; W J Dodds
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

8.  Mechanisms of gastroesophageal reflux in patients with reflux esophagitis.

Authors:  W J Dodds; J Dent; W J Hogan; J F Helm; R Hauser; G K Patel; M S Egide
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245

9.  Mechanisms responsible for gastroesophageal reflux in children.

Authors:  H Kawahara; J Dent; G Davidson
Journal:  Gastroenterology       Date:  1997-08       Impact factor: 22.682

10.  Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis.

Authors:  R K Mittal; R W McCallum
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

View more
  12 in total

1.  Acid infusion into the esophagus increases the number of meal-induced transient lower esophageal sphincter relaxations (TLESRs) in healthy volunteers.

Authors:  J Halicka; P Banovcin; M Halickova; M Demeter; R Hyrdel; M Tatar; M Kollarik
Journal:  Neurogastroenterol Motil       Date:  2014-08-22       Impact factor: 3.598

2.  Effects of mosapride on esophageal motor activity and esophagogastric junction compliance in healthy volunteers.

Authors:  Kousuke Fukazawa; Kenji Furuta; Kyoichi Adachi; Yoshiya Moritou; Tsukasa Saito; Ryusaku Kusunoki; Goichi Uno; Shino Shimura; Masahito Aimi; Shunji Ohara; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2013-09-07       Impact factor: 7.527

Review 3.  Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.

Authors:  Katsuhiko Iwakiri; Yoshikazu Kinoshita; Yasuki Habu; Tadayuki Oshima; Noriaki Manabe; Yasuhiro Fujiwara; Akihito Nagahara; Osamu Kawamura; Ryuichi Iwakiri; Soji Ozawa; Kiyoshi Ashida; Shuichi Ohara; Hideyuki Kashiwagi; Kyoichi Adachi; Kazuhide Higuchi; Hiroto Miwa; Kazuma Fujimoto; Motoyasu Kusano; Yoshio Hoshihara; Tatsuyuki Kawano; Ken Haruma; Michio Hongo; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-06-21       Impact factor: 7.527

4.  The role of excessive esophageal acid exposure in patients with gastroesophageal reflux disease.

Authors:  Katsuhiko Iwakiri
Journal:  Clin J Gastroenterol       Date:  2009-12-05

5.  Endoscopic diagnosis of hiatus hernia under deep inspiration is not consistent with esophageal manometric diagnosis.

Authors:  Yuriko Hanada; Shintaro Hoshino; Yoshimasa Hoshikawa; Nana Takenouchi; Mariko Umezawa; Noriyuki Kawami; Katsuhiko Iwakiri
Journal:  J Gastroenterol       Date:  2017-10-26       Impact factor: 7.527

Review 6.  Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021.

Authors:  Katsuhiko Iwakiri; Yasuhiro Fujiwara; Noriaki Manabe; Eikichi Ihara; Shiko Kuribayashi; Junichi Akiyama; Takashi Kondo; Hiroshi Yamashita; Norihisa Ishimura; Yuichi Kitasako; Katsunori Iijima; Tomoyuki Koike; Nobuo Omura; Tsutomu Nomura; Osamu Kawamura; Shuichi Ohara; Soji Ozawa; Yoshikazu Kinoshita; Satoshi Mochida; Nobuyuki Enomoto; Tooru Shimosegawa; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2022-02-28       Impact factor: 7.527

7.  Effects of Metoclopramide on Esophageal Motor Activity and Esophagogastric Junction Compliance in Healthy Volunteers.

Authors:  Hironobu Mikami; Norihisa Ishimura; Kousuke Fukazawa; Mayumi Okada; Daisuke Izumi; Shino Shimura; Eiko Okimoto; Masahito Aimi; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  J Neurogastroenterol Motil       Date:  2016-01-31       Impact factor: 4.924

8.  Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance.

Authors:  Hironobu Mikami; Norihisa Ishimura; Mayumi Okada; Daisuke Izumi; Eiko Okimoto; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  J Neurogastroenterol Motil       Date:  2018-04-30       Impact factor: 4.924

9.  Rationale and design of the VISION study: a randomized, open-label study to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive esophagitis.

Authors:  Naomi Uemura; Yoshikazu Kinoshita; Ken Haruma; Takashi Yao; Ryoji Kushima; Tatsuhiro Kanoo
Journal:  Clin Exp Gastroenterol       Date:  2018-01-24

10.  Evaluations of Gastric Acid Pocket Using Novel Vertical 8-Channel pH Monitoring System and Effects of Acid Secretion Inhibitors.

Authors:  Shohei Sumi; Norihisa Ishimura; Hironobu Mikami; Eiko Okimoto; Yuji Tamagawa; Tsuyoshi Mishiro; Yoshikazu Kinoshita; Shunji Ishihara
Journal:  J Neurogastroenterol Motil       Date:  2021-07-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.